Navigation Links
DelMar Pharmaceuticals Gives Quarterly Shareholder Update
Date:11/11/2013

.  Guangxi Wuzhou Pharmaceuticals will provide funding for clinical trials conducted in China and will be the exclusive supplier of VAL-083, and DelMar will be responsible for undertaking clinical development and commercialization activities.

We are continuing our efforts to secure a sales and marketing partner for VAL-083 in China. We are in discussions with potential partners who have who have significant experience marketing oncology products in the China marketplace and who could be valuable in helping to position VAL-083 within this market.  Our goal is to establish a sales and marketing relationship that will provide DelMar with ongoing royalty payments from sales in the China market.

We Are Attempting to Create Important New Medicines for Patients and Increased Value for Shareholders
On behalf of the entire DelMar Pharma team, I thank you for your continued support of our mission to develop and commercialize proven medicines for patients who have failed currently available therapy.  As always, our goal remains to serve patients who have unmet clinical needs and to build value for our shareholders in the timeliest manner possible.   

With warm personal regards,

Jeffrey A. Bacha
President and CEO
DelMar Pharmaceuticals

Twitter @DelMarPharma
Facebook.com/DelMarPharma

Safe Harbor Statement
Any statements contained in this update that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but a
'/>"/>

SOURCE DelMar Pharmaceuticals
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. DelMar Pharmaceuticals Presents Data Supporting VAL-083 as a Potential Treatment for Three Chemotherapy Resistant Cancers
2. DelMar Pharma reviews glioblastoma clinical trials and new therapeutic development on CEOLIVE.TV
3. DelMar Pharmaceuticals and Guangxi Wuzhou Pharmaceuticals Establish Clinical Advisory Board in China
4. DelMar Pharmaceuticals To Present At The 15th Annual Rodman & Renshaw Global Investment Conference
5. DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
6. DelMar Pharmaceuticals Presents Additional Clinical Data from Ongoing Brain Cancer Study at ASCO
7. DelMar Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com June 6th
8. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
9. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
10. DelMar Pharma Presents Encouraging Data From Ongoing Phase I/II GBM Clinical Trial With VAL-083
11. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 The leading companies ... billion global cardiac rhythm management device market dominate ... that Medtronic, St. Jude Medical, Boston Scientific and ... this market segment. The healthcare market research publisher,s ... uses 2015 as a base year, providing forecasts ...
(Date:5/22/2015)... YORK , May 22, 2015  The ... of Zarxio (filgrastim-sndz) -- the first biosimilar product ... -- points toward growth in the contract ... The mainstream CMO industry is geared to the ... to produce major biopharmaceutical products. The healthcare market ...
(Date:5/22/2015)... May 22, 2015  The Mesothelioma Victims Center ... of mesothelioma get the best possible compensation, and they ... with this rare cancer caused by exposure to ... information related to treatment options such as a ... the Mesothelioma Victims Center anytime at 866-714-6466. ...
Breaking Medicine Technology:Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5
... Company Focused on IND-Enabling Work with Protein Therapeutics that ... Modulate Alternative Pathway of Complement System, CAMBRIDGE, ... has initiated a corporate growth plan with the,appointment of ... of its headquarters in Cambridge, Mass. Dr. Celniker succeeds,Woodruff ...
... Nonin Medical, a leading innovator,of physiological monitoring solutions ... testing phase with its breakthrough technology to measure,regional ... is the continuous monitoring of the regional blood ... testing data and outcomes from an ongoing clinical ...
Cached Medicine Technology:Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 2Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters 3Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2
(Date:5/26/2015)... 26, 2015 Writers and editors ... the Vasont® CCMS to make creating, editing, and ... top component content management system (CCMS) software provider, ... supports oXygen XML Editor Version 17.0, Syncro Soft’s ... Integrator extension merges key editorial functionality of the ...
(Date:5/26/2015)... The European imaging IT market will grow ... healthcare providers plan to make purchases. , Over 240 ... collected from these participants show that speech recognition is a ... seat. , “Many imaging IT vendors are poised to ... Jeremy Bikman. “This report details the European market in ways ...
(Date:5/26/2015)... 26, 2015 The Brain Aneurysm Foundation ... Pops and their renowned Conductor Keith Lockhart will once ... evening, June 10, 2015—the 4th Annual Brain Aneurysm ... Pops Night is set to feature an exclusive Brain ... Keith Lockhart who tragically lost his sister-in-law to a ...
(Date:5/25/2015)... TX (PRWEB) May 26, 2015 ... 2015” provides comprehensive information on the therapeutic development ... by identifying new targets and MOAs to produce ... 2015 pipeline review of Liver Failure with 22 ... 65 pages is available at http://www.rnrmarketresearch.com/liver-failure-pipeline-review-h1-2015-market-report.html ...
(Date:5/25/2015)... City, NY (PRWEB) May 26, 2015 ... (NAPW) honors Dr. Heather Stanley-Christian ... of the Year Circle. She is recognized with ... is the nation's leading networking organization exclusively for ... over 200 operating local chapters. , "I'm pleased ...
Breaking Medicine News(10 mins):Health News:Vasont Systems Certifies the Integration between the Vasont® Component Content Management System and oXygen® XML Editor 17.0 2Health News:peer60 report: European Healthcare IT Imaging Purchases: 2015 2Health News:Boston Pops & Renowned Conductor Keith Lockhart to Join the Brain Aneurysm Foundation for the 4th Annual Brain Aneurysm Foundation Night at the Pops 2Health News:Liver Failure Pipeline Assessment and Key Players Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Liver Failure Pipeline Assessment and Key Players Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Liver Failure Pipeline Assessment and Key Players Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:NAPW Inducts Dr. Heather Stanley-Christian, Systems Chair/Maternal Fetal Medicine at Stroger Hospital, into Its VIP Professional Woman of the Year Circle 2
... New Courses Improve Patient Care and Address State ... (Health Care Compliance,Strategies, Inc.), the leading provider of ... partnership with University,HealthSystem Consortium (UHC) to deliver a ... of 11 courses with multimedia content and,healthcare specific ...
... Irvine Department of Emergency Medicine is hosting the 11th ... 28-29 in Costa Mesa, Calif. As part of the ... findings on a variety of related areas ranging from ... the success of computerized alcohol-use counseling. , ...
... HARRISBURG, Pa., March 26 Governor Edward G.,Rendell today ... Pennsylvanians to begin planning ahead to better meet their ... not something that can be put off. If,people do ... expensive,consequences," Governor Rendell said. "The ,Own Your Future, campaign,empowers ...
... London and Hospital for Sick Kids purchase Open Access ... ... Open Biosystems, Inc.,announced today that two leading research institutions, University ... Canada, have,recently purchased access to Open Biosystems, shRNAmir technologies for,RNAi ...
... of pediatric liver transplant recipients report lower health-related ... after the surgery, compared to reports from the ... dysfunction fall within the normal range. These findings ... Transplantation. The article is also available online at ...
... 26 Target Data Research (TDR),President R.J. Slutz announced ... Forward fund raising campaign which will be held at ... support Step,N Forward and the Office of Public,Guardianship, Advanced ... quality of life and develop strategies to raise the ...
Cached Medicine News:Health News:HCCS Partners With UHC to Deliver Cultural Competency Courses 2Health News:HCCS Partners With UHC to Deliver Cultural Competency Courses 3Health News:UC Irvine researchers present latest findings at emergency medicine forum 2Health News:Governor Rendell Announces 'Own Your Future' Campaign; Urges Consumers to Better Plan Their Long-Term Care Needs 2Health News:Open Biosystems' Open Access RNAi Program Continues to Gain Momentum Worldwide 2Health News:Open Biosystems' Open Access RNAi Program Continues to Gain Momentum Worldwide 3Health News:Study shows lifetime effects of pediatric liver transplants 2
Phacoemulsification system is a complete anterior segment surgical instrument. Its simplified design and unique innovations provide optimal surgical performance....
A gentle yet highly effective corneal rust ring remover with Alger brush of 1mm burr. Runs off 1 x AA battery, no switches, simply spin mandrel to operate....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings....
Foreign body removal system. Designed to aid in the removal of foreign bodies and corneal rust rings. Ophtho-burr handpiece only. Battery powered handpiece....
Medicine Products: